These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23921600)

  • 1. The SafeBoosC phase II randomised clinical trial: a treatment guideline for targeted near-infrared-derived cerebral tissue oxygenation versus standard treatment in extremely preterm infants.
    Pellicer A; Greisen G; Benders M; Claris O; Dempsey E; Fumagalli M; Gluud C; Hagmann C; Hellström-Westas L; Hyttel-Sorensen S; Lemmers P; Naulaers G; Pichler G; Roll C; van Bel F; van Oeveren W; Skoog M; Wolf M; Austin T
    Neonatology; 2013; 104(3):171-8. PubMed ID: 23921600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical use of cerebral oximetry in extremely preterm infants is feasible.
    Hyttel-Sørensen S; Austin T; van Bel F; Benders M; Claris O; Dempsey EM; Fumagalli M; Gluud C; Hagmann C; Hellström-Westas L; Lemmers P; Naulaers G; van Oeveren W; Pellicer A; Pichler G; Roll C; Støy LS; Wolf M; Greisen G
    Dan Med J; 2013 Jan; 60(1):A4533. PubMed ID: 23340184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase II randomized clinical trial on cerebral near-infrared spectroscopy plus a treatment guideline versus treatment as usual for extremely preterm infants during the first three days of life (SafeBoosC): study protocol for a randomized controlled trial.
    Hyttel-Sorensen S; Austin T; van Bel F; Benders M; Claris O; Dempsey E; Fumagalli M; Greisen G; Grevstad B; Hagmann C; Hellström-Westas L; Lemmers P; Lindschou J; Naulaers G; van Oeveren W; Pellicer A; Pichler G; Roll C; Skoog M; Winkel P; Wolf M; Gluud C
    Trials; 2013 May; 14():120. PubMed ID: 23782447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral near infrared spectroscopy oximetry in extremely preterm infants: phase II randomised clinical trial.
    Hyttel-Sorensen S; Pellicer A; Alderliesten T; Austin T; van Bel F; Benders M; Claris O; Dempsey E; Franz AR; Fumagalli M; Gluud C; Grevstad B; Hagmann C; Lemmers P; van Oeveren W; Pichler G; Plomgaard AM; Riera J; Sanchez L; Winkel P; Wolf M; Greisen G
    BMJ; 2015 Jan; 350():g7635. PubMed ID: 25569128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The SafeBoosC phase II clinical trial: an analysis of the interventions related with the oximeter readings.
    Riera J; Hyttel-Sorensen S; Bravo MC; Cabañas F; López-Ortego P; Sanchez L; Ybarra M; Dempsey E; Greisen G; Austin T; Claris O; Fumagalli M; Gluud C; Lemmers P; Pichler G; Plomgaard AM; van Bel F; Wolf M; Pellicer A
    Arch Dis Child Fetal Neonatal Ed; 2016 Jul; 101(4):F333-8. PubMed ID: 26645538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral near-infrared spectroscopy monitoring versus treatment as usual for extremely preterm infants: a protocol for the SafeBoosC randomised clinical phase III trial.
    Hansen ML; Pellicer A; Gluud C; Dempsey E; Mintzer J; Hyttel-Sørensen S; Heuchan AM; Hagmann C; Ergenekon E; Dimitriou G; Pichler G; Naulaers G; Cheng G; Guimarães H; Tkaczyk J; Kreutzer KB; Fumagalli M; Claris O; Lemmers P; Fredly S; Szczapa T; Austin T; Jakobsen JC; Greisen G
    Trials; 2019 Dec; 20(1):811. PubMed ID: 31888764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early biomarkers of brain injury and cerebral hypo- and hyperoxia in the SafeBoosC II trial.
    Plomgaard AM; Alderliesten T; Austin T; van Bel F; Benders M; Claris O; Dempsey E; Fumagalli M; Gluud C; Hagmann C; Hyttel-Sorensen S; Lemmers P; van Oeveren W; Pellicer A; Petersen TH; Pichler G; Winkel P; Greisen G
    PLoS One; 2017; 12(3):e0173440. PubMed ID: 28328980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detailed statistical analysis plan for the SafeBoosC III trial: a multinational randomised clinical trial assessing treatment guided by cerebral oxygenation monitoring versus treatment as usual in extremely preterm infants.
    Hansen ML; Pellicer A; Gluud C; Dempsey E; Mintzer J; Hyttel-Sorensen S; Heuchan AM; Hagmann C; Dimitriou G; Pichler G; Naulaers G; Cheng G; Vilan A; Tkaczyk J; Kreutzer KB; Fumagalli M; Claris O; Fredly S; Szczapa T; Lange T; Jakobsen JC; Greisen G
    Trials; 2019 Dec; 20(1):746. PubMed ID: 31856902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral oxygenation during skin-to-skin care in preterm infants not receiving respiratory support.
    Lorenz L; Marulli A; Dawson JA; Owen LS; Manley BJ; Donath SM; Davis PG; Kamlin COF
    Arch Dis Child Fetal Neonatal Ed; 2018 Mar; 103(2):F137-F142. PubMed ID: 28747364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilot test of an online training module on near-infrared spectroscopy monitoring for the randomised clinical trial SafeBoosC-III.
    Hansen ML; Rasmussen MI; Rubin S; Pellicer A; Cheng G; Xu X; Zhaoqing Y; Zoffmann V; Greisen G
    Trials; 2020 Apr; 21(1):356. PubMed ID: 32326953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral desaturations in preterm infants: a crossover trial on influence of oxygen saturation target range.
    Schmid MB; Hopfner RJ; Lenhof S; Hummler HD; Fuchs H
    Arch Dis Child Fetal Neonatal Ed; 2013 Sep; 98(5):F392-8. PubMed ID: 23457220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral regional tissue Oxygen Saturation to Guide Oxygen Delivery in preterm neonates during immediate transition after birth (COSGOD III): an investigator-initiated, randomized, multi-center, multi-national, clinical trial on additional cerebral tissue oxygen saturation monitoring combined with defined treatment guidelines versus standard monitoring and treatment as usual in premature infants during immediate transition: study protocol for a randomized controlled trial.
    Pichler G; Baumgartner S; Biermayr M; Dempsey E; Fuchs H; Goos TG; Lista G; Lorenz L; Karpinski L; Mitra S; Kornhauser-Cerar L; Avian A; Urlesberger B; Schmölzer GM
    Trials; 2019 Mar; 20(1):178. PubMed ID: 30894226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional differences in tissue oxygenation during cardiopulmonary bypass for correction of congenital heart disease in neonates and small infants: relevance of near-infrared spectroscopy.
    Redlin M; Koster A; Huebler M; Boettcher W; Nagdyman N; Hetzer R; Kuppe H; Kuebler WM
    J Thorac Cardiovasc Surg; 2008 Oct; 136(4):962-7. PubMed ID: 18954637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient hyperoxia does not affect regional cerebral tissue oxygen saturation in moderately preterm or term newborns.
    Thing M; Sørensen LC; Pryds O
    Acta Paediatr; 2015 Jul; 104(7):657-62. PubMed ID: 25382627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No neurodevelopmental benefit of cerebral oximetry in the first randomised trial (SafeBoosC II) in preterm infants during the first days of life.
    Plomgaard AM; Alderliesten T; van Bel F; Benders M; Claris O; Cordeiro M; Dempsey E; Fumagalli M; Gluud C; Hyttel-Sorensen S; Lemmers P; Pellicer A; Pichler G; Greisen G
    Acta Paediatr; 2019 Feb; 108(2):275-281. PubMed ID: 29908039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current research suggests that the future looks brighter for cerebral oxygenation monitoring in preterm infants.
    Kenosi M; Naulaers G; Ryan CA; Dempsey EM
    Acta Paediatr; 2015 Mar; 104(3):225-31. PubMed ID: 25557591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain oxygenation monitoring during neonatal resuscitation of very low birth weight infants.
    Fuchs H; Lindner W; Buschko A; Almazam M; Hummler HD; Schmid MB
    J Perinatol; 2012 May; 32(5):356-62. PubMed ID: 21852771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reference ranges for regional cerebral tissue oxygen saturation and fractional oxygen extraction in neonates during immediate transition after birth.
    Pichler G; Binder C; Avian A; Beckenbach E; Schmölzer GM; Urlesberger B
    J Pediatr; 2013 Dec; 163(6):1558-63. PubMed ID: 23972642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early cerebral hypoxia in extremely preterm infants and neurodevelopmental impairment at 2 year of age: A post hoc analysis of the SafeBoosC II trial.
    Plomgaard AM; Schwarz CE; Claris O; Dempsey EM; Fumagalli M; Hyttel-Sorensen S; Lemmers P; Pellicer A; Pichler G; Greisen G
    PLoS One; 2022; 17(1):e0262640. PubMed ID: 35073354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral and somatic rSO2 in sick preterm infants.
    Cerbo RM; Cabano R; Di Comite A; Longo S; Maragliano R; Stronati M
    J Matern Fetal Neonatal Med; 2012 Oct; 25 Suppl 4():97-100. PubMed ID: 22958033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.